Filter
1794
Filtered Results: 1794
Text search:
self-efficacy
Featured
Recommendations
187
New Publications
397
Language
Document type
No document type
991
Studies & Reports
290
Guidelines
285
Manuals
92
Strategic & Response Plan
58
Training Material
34
Fact sheets
23
Situation Updates
6
Resource Platforms
6
Infographics
5
Brochures
3
Online Courses
1
Countries / Regions
Global
82
India
74
Kenya
47
South Africa
43
Western and Central Europe
33
Nigeria
32
Uganda
32
Ethiopia
29
Nepal
23
Tanzania
22
Zambia
21
Malawi
21
Africa
20
Sierra Leone
19
Latin America and the Carribbean
19
Ghana
18
Bangladesh
18
Philippines
17
Liberia
16
South–East Asia Region
16
Eastern Europe
15
Myanmar / Burma
14
Rwanda
13
Zimbabwe
12
Senegal
11
Congo, Democratic Republic of
11
Namibia
11
Lesotho
11
Russia
11
Burkina Faso
10
Pakistan
10
West and Central Africa
10
Cambodia
9
Ukraine
9
Botswana
9
Syria
8
Indonesia
8
East and Southern Africa
8
Middle East and North Africa
7
Cameroon
6
Germany
6
Mozambique
6
Brazil
6
Sri Lanka
6
Jordan
5
Eswatini/ Swaziland
5
Chile
5
Eastern Europe and Central Asia
5
Asia
5
Laos
5
Guinea
4
Haiti
4
China
4
Sudan
4
Georgia
4
Vietnam
4
North America
4
Côte d’Ivoire / Ivory Coast
3
USA
3
Somalia
3
Iraq
3
Afghanistan
3
Benin
3
Central African Republic
3
Peru
3
Western Pacific Region
3
Tajikistan
3
Iran
3
United Kingdom
3
Mali
2
Morocco
2
Niger
2
Lebanon
2
Turkey
2
Egypt
2
Thailand
2
Argentina
2
Ecuador
2
Madagascar
2
Yemen
2
Italy
2
Armenia
2
Gabon
2
Tunisia
2
Saudi Arabia
1
South Sudan
1
Chad
1
Ireland
1
Singapore
1
Papua New Guinea
1
North Macedonia
1
Burundi
1
Honduras
1
Greece
1
Mexico
1
Fiji
1
Bhutan
1
Venezuela
1
Albania
1
Congo-Brazzaville
1
Canada
1
Australia
1
Belgium
1
France
1
Mauritius
1
Belarus
1
Authors & Publishers
Publication Years
Category
Countries
558
Clinical Guidelines
171
Public Health
128
Women & Child Health
85
Key Resources
50
Capacity Building
38
Pharmacy & Technologies
16
Toolboxes
Mental Health
283
HIV
165
COVID-19
159
AMR
84
TB
67
Disability
61
NCDs
61
Pharmacy
57
NTDs
50
Caregiver
49
Ebola
44
Rapid Response
42
Planetary Health
30
Refugee
24
Conflict
12
Global Health Education
11
Cholera
9
Social Ethics
9
Health Financing Toolbox
9
Natural Hazards
8
Zika
7
Polio
6
Specific Hazards
6
Health Financing
1
It is Zika virus (ZIKV) that most often causes these neurological effects it appears to be the only arbovirus than can cause congenital malformations such as microcephaly. In any case, more scientific tests are needed to establish the causal relationship between the virus and this malformation (7-10...
Download (7.4 MB)
Overview
Epilepsy is one of the most common neurological disorders globally. The WHO epilepsy technical brief aims to strengthen action for epilepsy and complements the Intersectoral global action plan on epilepsy and other neurological disorders 2022–2031.
The technical bri...
This Mpox SPRP Global Monitoring & Evaluation (M&E) Framework, also referred to as the Framework, aims to monitor and report on global progress towards these objectives, including information about country-level response efforts and WHO support to Member States. Regular collection and analysis of da...
This document outlines the working structure and guiding principles for collaboration of COVAX, the Vaccines pillar of the Access to COVID-19 Tools Accelerator (ACT-A). The working structure of COVAX continues to adapt to emerging needs and the changing trajectory of the pandemic. Some components of...
The indicators and questions in this document are designed for use by national AIDS programmes and partners to assess the state of a country’s HIV and AIDS response, and to measure progress towards achieving national HIV targets. Countries are encouraged to integrate these indicators and questions...
This Trachoma Action Planning – a planning guide – is published by the
International Coalition for Trachoma Control at the request of the
World Health Organization Alliance for the Global Elimination of Trachoma
by 2020.
This publication represents a key step forward in translating Control of the leishmaniases (WHO Technical Report Series, No. 949) into a more practical tool for health personnel directly involved in the case management of cutaneous leishmaniasis. With this manual, countries will have, for the first ...
In 2011, ICTC developed a Trachoma Action Plan (TAP) planning guide to support national health officials in endemic countries. This resource was developed to complement the 2020 INSight roadmap by helping countries create specific national plans detailing how they will reach elimination targets in t...
Over 6 million people worldwide are infected with Trypanosoma cruzi, the protozoan that causes Chagas disease
(CD). T. cruzi is transmitted by triatomine insects, congenitally, through uncontrolled blood donations and organ transplants,
and via consumption of food or drink contaminated by triatomi...
Pharmaceutical News
Evaluation of Saccharide Content of the WHO 2nd International Standard for Haemophilus Influenzae Polysaccharide Polyribosyl Ribitol Phosphate (PRP) by HPAECPAD Analysis Following Acid Hydrolysis
Consultation Documents
Lamivudine and tenofovir disoproxil fumarate tablets (lami...
The World Health Organization (WHO) and the global community of countries, partners, donors, technical experts, scientists and field implementation teams continue to work towards the ultimate goal of a world free of the burden of neglected tropical diseases (NTDs).
This guideline for the prevention and control of chikungunya fever
(CF) is intended for use by all peripheral health workers in the Region and
is based on the strategy outlined above. This document will focus mainly
on preventing, predicting and detecting outbreaks, and after detection,
investig...
The aim of this toolkit is to guide countries on how to best estimate their current burden of dengue by combining existing data from dengue surveillance systems with on-going research efforts to measure the community burden
of dengue.
Human schistosomiasis, a parasitic and often chronic illness, is one of the major neglected tropical diseases worldwide. It is estimated that 240 million people suffer from schistosomiasis, with more than 200000 fatalities recorded each year. Schistosomiasis is caused by an infection of the blood fl...
In support of the London Declaration goals, PATH aims to catalyze engagement of the diagnostics industry and product development efforts. As part of this work, PATH conducted a diagnostic landscape analysis to identify gaps and evaluated current and nascent HAT diagnostics that may provide solutions...
This technical report presents the epidemiology of human and animal leishmaniases in the EU and its neighbouring countries and concludes that the disease remains widespread and underreported in many countries of southern Europe, northern Africa, and the Middle East and that there is a need to improv...
In May the Sixty-sixth World Health Assembly adopted resolution WHA66.12 (1) on 17 neglected tropical diseases (NTDs). Among other measures, the resolution urges Member States to:
• ensure country ownership of prevention, control, elimination and eradication programmes;
• expand and implemen...
An interregional meeting on leishmaniasis among neighbouring endemic
countries in the Eastern Mediterranean, African and European regions was organized by the World Health Organization (WHO) Regional Office for the Eastern
Mediterranean in Amman, Jordan, from 23 to 25 September 2018. The meeting w...
This analysis focused on the chronic form of HAT caused by T. b. gambiense, as it contributes to the majority of disease burden. Information from the literature review,
product development landscape, and stakeholder interviews was compiled to:
- Identify use cases and understand current diagnosti...
Snakebite envenoming constitutes a serious medical condition that primarily affects residents of rural communities in Africa, Asia, Latin America, and New Guinea. It is an occupational, environmental, and domestic health hazard that exacerbates the already impoverished state of these communities. Co...
